FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 124 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,054,000 | -96.4% | 27,983 | -98.4% | 0.00% | -100.0% |
| Q4 2020 | $28,877,000 | +33872.9% | 1,697,659 | +4439.6% | 0.00% | – |
| Q1 2020 | $85,000 | -6.6% | 37,397 | +88.9% | 0.00% | – |
| Q4 2019 | $91,000 | +30.0% | 19,797 | +9.1% | 0.00% | – |
| Q3 2019 | $70,000 | -35.8% | 18,139 | +0.8% | 0.00% | – |
| Q2 2019 | $109,000 | -99.2% | 18,003 | -98.2% | 0.00% | -100.0% |
| Q1 2019 | $13,701,000 | +42.6% | 1,022,447 | -1.1% | 0.00% | 0.0% |
| Q4 2018 | $9,610,000 | -33.7% | 1,033,318 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $14,494,000 | -11.7% | 1,041,254 | +0.3% | 0.00% | -33.3% |
| Q2 2018 | $16,410,000 | -15.8% | 1,037,941 | -8.5% | 0.00% | 0.0% |
| Q1 2018 | $19,483,000 | +216.1% | 1,134,065 | +303.3% | 0.00% | +200.0% |
| Q4 2017 | $6,164,000 | +281.7% | 281,207 | +620.2% | 0.00% | – |
| Q2 2016 | $1,615,000 | -87.8% | 39,045 | -87.7% | 0.00% | -100.0% |
| Q4 2015 | $13,221,000 | +40.9% | 318,580 | -47.7% | 0.00% | +50.0% |
| Q3 2015 | $9,382,000 | -39.2% | 609,620 | -1.8% | 0.00% | -33.3% |
| Q2 2015 | $15,421,000 | +8.4% | 620,810 | -0.3% | 0.00% | 0.0% |
| Q1 2015 | $14,227,000 | +26.2% | 622,610 | +49.1% | 0.00% | +50.0% |
| Q4 2014 | $11,275,000 | +283.2% | 417,610 | +66.5% | 0.00% | +100.0% |
| Q3 2014 | $2,942,000 | – | 250,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|